Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24680 participants
INTERVENTIONAL
2021-10-25
2022-04-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Promoting Breast Cancer Screening in Non-adherent Women
NCT01332032
Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study
NCT02514499
Patient Centered Randomized Controlled Trial
NCT00233077
Study on Breast Cancer Patient Perspectives of Exercise
NCT02559362
A Patient Reminder and Self-Referral Via Online Patient Portals and Text Messaging to Improve Adherence to Breast Cancer Screening
NCT05526872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No Order
No Bulk Order
The outreach will ask patients to contact their PCP's office in order to have a mammogram order placed on their behalf.
No Order + Text (NO+T)
Texting
In addition to outreach, patients will receive text messaging with information regarding the importance of screening, how to schedule a mammogram, and locations available for mammography.
No Bulk Order
The outreach will ask patients to contact their PCP's office in order to have a mammogram order placed on their behalf.
Bulk Order (BO)
Bulk Order
A mammogram order will be placed using bulk order technology in the EHR in advance of outreach for all patients.
Bulk Order + Text (BO+T)
Bulk Order
A mammogram order will be placed using bulk order technology in the EHR in advance of outreach for all patients.
Texting
In addition to outreach, patients will receive text messaging with information regarding the importance of screening, how to schedule a mammogram, and locations available for mammography.
Clinician Endorsement (CE)
Clinician Endorsement
Outreach informing patients that they are overdue for a mammogram will be signed by the patient's primary care provider.
Clinician Endorsement + Text (CE+T)
Texting
In addition to outreach, patients will receive text messaging with information regarding the importance of screening, how to schedule a mammogram, and locations available for mammography.
Clinician Endorsement
Outreach informing patients that they are overdue for a mammogram will be signed by the patient's primary care provider.
Standard Messaging (SM)
Standard Endorsement
Patient's will receive outreach from the practice informing them that they are overdue for a mammogram.
Standard Messaging (SM+T)
Texting
In addition to outreach, patients will receive text messaging with information regarding the importance of screening, how to schedule a mammogram, and locations available for mammography.
Standard Endorsement
Patient's will receive outreach from the practice informing them that they are overdue for a mammogram.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bulk Order
A mammogram order will be placed using bulk order technology in the EHR in advance of outreach for all patients.
Texting
In addition to outreach, patients will receive text messaging with information regarding the importance of screening, how to schedule a mammogram, and locations available for mammography.
Clinician Endorsement
Outreach informing patients that they are overdue for a mammogram will be signed by the patient's primary care provider.
No Bulk Order
The outreach will ask patients to contact their PCP's office in order to have a mammogram order placed on their behalf.
Standard Endorsement
Patient's will receive outreach from the practice informing them that they are overdue for a mammogram.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Followed by Primary Care with a Penn Medicine PCP listed and at least one visit in the last 2 years
3. Health Maintenance due (default biannual screening starting at age 50 or edit modifier based on input by clinician)
Exclusion Criteria
2. History of bilateral mastectomy
40 Years
74 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abramson Cancer Center at Penn Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shivan Mehta
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shivan Mehta, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Penn Medicine
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mehta SJ, Rhodes C, Linn KA, Reitz C, McDonald C, Okorie E, Williams K, Resnick D, Arostegui A, McAuliffe T, Wollack C, Snider CK, Peifer MK, Weinstein SP. Behavioral Interventions to Improve Breast Cancer Screening Outreach: Two Randomized Clinical Trials. JAMA Intern Med. 2024 Jul 1;184(7):761-768. doi: 10.1001/jamainternmed.2024.0495.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
849863
Identifier Type: OTHER
Identifier Source: secondary_id
UPCC 15121
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.